Abstract
New drug design possibilities are suggested by the results of a biological evaluation of the indole derivative 1 of pancratistatin, a known anticancer agent, in a panel of cancer cell lines. Enzymatic dihydroxylation was one of the key steps in the short, enantioselective synthesis of 1.
Original language | English |
---|---|
Pages (from-to) | 5342-5346 |
Number of pages | 5 |
Journal | Angew. Chem. Int. Ed. |
Volume | 43 |
Issue number | 40 |
DOIs | |
Publication status | Published - 5 Oct 2004 |
Externally published | Yes |
Keywords
- Antitumor agents
- Asymmetric synthesis
- Natural products
- Pancratistatin
- Synthetic methods
- Amaryllidaceae Alkaloids
- Antineoplastic Agents, Phytogenic
- Carbolines
- Hydrogen Bonding
- Isoquinolines
- Molecular Mimicry
- Molecular Structure
- Plants, Medicinal
- Stereoisomerism
- Cells
- Synthesis (chemical)
- Tumors
- 7 deoxypancratistatin
- beta carbolin 1 one
- beta carboline derivative
- hydroxyl group
- lycoricidine
- narciclasine
- natural product
- pancratistatin
- phenanthridine derivative
- unclassified drug
- amaryllidaceae
- antineoplastic activity
- article
- asymmetric synthesis
- electricity
- geometry
- molecular model
- nuclear magnetic resonance imaging
- pharmacophore
- plant
- RNA transcription
- Enzymatic dihydroxylation
- Indole derivatives
- Drug therapy
Research fields
- Alkaloids
- Amaryllidaceae alkaloids
- Total Synthesis
- Stereoselective synthesis
- Structure-activity relationship
IMC Research Focuses
- Materials science
ÖFOS 2012 - Austrian Fields of Study
- 104015 Organic chemistry
- 104013 Natural product chemistry
- 301305 Medical chemistry